Joanna Stankiewicz, Ewa Demidowicz, Natalia Bartoszewicz, A. Kołtan, S. Koltan, Krzysztof Czyżewski, Monika Richert-Przygonska, R. Dębski, M. Pogorzała, Barbara Tejza, Joanna Cisek, Piotr Księżniakiewicz, Agnieszka Jatczak-Gaca, Marlena Salamon, Agata Marjańska, Anna H. Dąbrowska, E. Grześk, A. Urbańczyk, Kamila Jaremek, Monika Łęcka, Eugenia Winogrodzka, Monika Adamkiewicz, Dominika Kołuda, Sandra Wałach, Oliwia Grochowska, S. Tarasenko, Marta Mazalon, M. Dziedzic, M. Kubicka, Beata Kuryło-Rafińska, J. Styczyński
{"title":"复发儿童急性髓性白血病:预后因素和结果:来自单一肿瘤中心的经验","authors":"Joanna Stankiewicz, Ewa Demidowicz, Natalia Bartoszewicz, A. Kołtan, S. Koltan, Krzysztof Czyżewski, Monika Richert-Przygonska, R. Dębski, M. Pogorzała, Barbara Tejza, Joanna Cisek, Piotr Księżniakiewicz, Agnieszka Jatczak-Gaca, Marlena Salamon, Agata Marjańska, Anna H. Dąbrowska, E. Grześk, A. Urbańczyk, Kamila Jaremek, Monika Łęcka, Eugenia Winogrodzka, Monika Adamkiewicz, Dominika Kołuda, Sandra Wałach, Oliwia Grochowska, S. Tarasenko, Marta Mazalon, M. Dziedzic, M. Kubicka, Beata Kuryło-Rafińska, J. Styczyński","doi":"10.5603/ahp.a2023.0036","DOIUrl":null,"url":null,"abstract":"Introduction: Over recent decades, significant progress in the treatment of childhood acute myeloid leukemia (AML) has been made. However, the relapsed disease remains a challenge. The aim of this study was to analyze therapy results in pediatric patients treated for relapsed AML in a single oncology center","PeriodicalId":35805,"journal":{"name":"Acta Haematologica Polonica","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Relapsed childhood acute myeloid leukemia: prognostic factors and outcomes: experience from a single oncology center\",\"authors\":\"Joanna Stankiewicz, Ewa Demidowicz, Natalia Bartoszewicz, A. Kołtan, S. Koltan, Krzysztof Czyżewski, Monika Richert-Przygonska, R. Dębski, M. Pogorzała, Barbara Tejza, Joanna Cisek, Piotr Księżniakiewicz, Agnieszka Jatczak-Gaca, Marlena Salamon, Agata Marjańska, Anna H. Dąbrowska, E. Grześk, A. Urbańczyk, Kamila Jaremek, Monika Łęcka, Eugenia Winogrodzka, Monika Adamkiewicz, Dominika Kołuda, Sandra Wałach, Oliwia Grochowska, S. Tarasenko, Marta Mazalon, M. Dziedzic, M. Kubicka, Beata Kuryło-Rafińska, J. Styczyński\",\"doi\":\"10.5603/ahp.a2023.0036\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: Over recent decades, significant progress in the treatment of childhood acute myeloid leukemia (AML) has been made. However, the relapsed disease remains a challenge. The aim of this study was to analyze therapy results in pediatric patients treated for relapsed AML in a single oncology center\",\"PeriodicalId\":35805,\"journal\":{\"name\":\"Acta Haematologica Polonica\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta Haematologica Polonica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5603/ahp.a2023.0036\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Haematologica Polonica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/ahp.a2023.0036","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
Relapsed childhood acute myeloid leukemia: prognostic factors and outcomes: experience from a single oncology center
Introduction: Over recent decades, significant progress in the treatment of childhood acute myeloid leukemia (AML) has been made. However, the relapsed disease remains a challenge. The aim of this study was to analyze therapy results in pediatric patients treated for relapsed AML in a single oncology center